These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6621714)

  • 1. Synthesis rate of dopamine: difference between corpus striatum and limbic system as a possible explanation of variations in reactions to drugs.
    Andén NE; Grabowska-Andén M; Lindgren S; Thornström U
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):193-8. PubMed ID: 6621714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H; Engberg G; Pileblad E
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of autoreceptors on dopamine neurons in different brain regions of rats treated with gammabutyrolactone.
    Andén NE; Grabowska-Andén M; Liljenberg B
    J Neural Transm; 1983; 58(3-4):143-52. PubMed ID: 6420514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamine synthesis in rat brain after axotomy: interaction between apomorphine and haloperidol.
    Kehr W; Carlsson A; Lindqvist M
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):111-7. PubMed ID: 193050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
    Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
    Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. d-Amphetamine and gamma-butyrolactone alteration of dopamine synthesis in the terminals of nigrostriatal and mesolimbic neurons. Possible role of various autoreceptor sensitivities.
    Demarest KT; Lawson-Wendling KL; Moore KE
    Biochem Pharmacol; 1983 Feb; 32(4):691-7. PubMed ID: 6403019
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of dopamine synthesis in mesolimbic dopamine neurons by immobilization stress in the rat.
    Watanabe H
    Neuropharmacology; 1984 Nov; 23(11):1335-8. PubMed ID: 6441893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in locomotion and dopamine neurotransmission following amphetamine, haloperidol, and exposure to novel environmental stimuli.
    Bardo MT; Bowling SL; Pierce RC
    Psychopharmacology (Berl); 1990; 101(3):338-43. PubMed ID: 2163539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners of 3-PPP.
    Hjorth S; Svensson K; Carlsson A; Wikström H; Andersson B
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):205-18. PubMed ID: 3762735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of drugs on striatal and limbic homovanillic acid concentration in the rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1975 Aug; 33(1):31-40. PubMed ID: 126169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist--antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation.
    Carlsson A; Kehr W; Lindqvist M
    J Neural Transm; 1977; 40(2):99-113. PubMed ID: 323424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of B-HT 920 and B-HT 933 on dopamine and noradrenaline autoreceptors in the rat brain.
    Andén NE; Nilsson H; Ros E; Thornström U
    Acta Pharmacol Toxicol (Copenh); 1983 Jan; 52(1):51-6. PubMed ID: 6301216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal changes in catecholamine synthesis of rat forebrain structures after axotomy.
    Kehr W
    J Neural Transm; 1974; 35(4):307-17. PubMed ID: 4436670
    [No Abstract]   [Full Text] [Related]  

  • 14. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
    Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW; Slimovitch C; Toffano G
    Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat.
    Ahlenius S; Hillegaart V; Wijkström A
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):551-6. PubMed ID: 2570361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors.
    Prosser ES; Csernansky JG; Hollister LE
    Life Sci; 1988; 43(8):715-20. PubMed ID: 2901023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation.
    Chivers JK; Reavill C; Jenner P; Marsden CD
    J Pharm Pharmacol; 1988 Sep; 40(9):613-9. PubMed ID: 2907027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of domperidone and haloperidol effects on different dopaminergic neurons in the rat brain.
    Farah JM; Demarest KT; Moore KE
    Life Sci; 1983 Oct; 33(16):1561-6. PubMed ID: 6633157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the dopamine agonist pergolide on tyrosine hydroxylase activity in rat striatal and limbic miniprisms in vitro: a model for the dopamine autoreceptor?
    Vulto AG; Fowler CJ
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):349-53. PubMed ID: 2877399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.